Old Web
English
Sign In
Acemap
>
authorDetail
>
Maria Cecilia Vieira
Maria Cecilia Vieira
Novartis
Medicine
Multiple sclerosis
Fingolimod
Diabetes mellitus
Physical therapy
5
Papers
21
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Review of Available Treatments, Clinical Evidence, and Guidelines for Diagnosis and Treatment of Pediatric Multiple Sclerosis in the United States:
2019
Journal of Child Neurology
Lauren Krupp
Maria Cecilia Vieira
Haley Toledano
Desi Peneva
Eric Druyts
Ping Wu
Fernanda C. Boulos
Show All
Source
Cite
Save
Citations (3)
Real-world durability of relapse rate reduction in patients with multiple sclerosis receiving fingolimod for up to 3 years: a retrospective US claims database analysis
2019
Journal of the Neurological Sciences
Edward Fox
Maria Cecilia Vieira
Kristen Johnson
Miranda Peeples
Arielle G. Bensimon
James Signorovitch
Vivian Herrera
Show All
Source
Cite
Save
Citations (2)
Time to treatment failure following initiation of fingolimod versus teriflunomide for multiple sclerosis: a retrospective U.S. claims study
2019
Current Medical Research and Opinion
Maria Cecilia Vieira
Devon S. Conway
Gina Mavrikis Cox
Miranda Peeples
Arielle G. Bensimon
Monica Macheca
Vivian Herrera
Show All
Source
Cite
Save
Citations (3)
Patient-Reported Disease-Modifying Therapy Adherence in the Clinic: A Reliable Metric?
2018
Devon Conway
Maria Cecilia Vieira
Nicolas R. Thompson
Kaila N Parker
Xiangyi Meng
Robert J. Fox
Show All
Source
Cite
Save
Citations (4)
Real-world persistence with fingolimod for the treatment of multiple sclerosis: A systematic review and meta-analysis
2018
Journal of the Neurological Sciences
Daniel Kantor
Kristen Johnson
Maria Cecilia Vieira
James Signorovitch
Nanxin Li
Wei Gao
Valerie Koo
Emilie Duchesneau
Vivian Herrera
Show All
Source
Cite
Save
Citations (9)
1
map